Sevelamer Carbonate Powder, For Suspension
Product Images NDC 69452-126

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 69452-126). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 3 (Figure 2)

This appears to be a graph showing the effect of Sevelamer Hydrochloride on serum phosphorus, with reductions shown on the Y-axis and the reduction in serum phosphorus in milligrams per deciliter shown on the X-axis. There are several data points indicating improvement or worsening, with a range of reductions shown from 0 to 10. There is also a legend indicating "Active Control" and various values for reduction or improvement.*

FDA Label Image

Figure 4: Mean Phosphorus Change From Baseline For Patients Who Completed 52 Weeks Of Treatment (Figure 3)

FDA Label Image

Image Description (Figure1)

This appears to be a table with various subgroups and measurements related to screening for dialysis patients. It includes data on baseline serum phosphorus levels, age, and whether or not the patient is on dialysis. It also includes data on the efficacy of two different treatments (Sevelamer Carb and Hecsho) based on various measurements.*

FDA Label Image

Image1

This is a prescription medication with Lemon flavor, identified by the National Drug Code (NDC) 69452-126-60, used for oral suspension, containing Sevelamer Carbonate.*

FDA Label Image

Image2

This text provides instructions for the use of sevelamer carbonate medication, including the weight per packet (0.8 g) and directions for use. It advises consulting the package insert for recommended dosing and storing the medication at controlled room temperature. It is distributed by Bionpharma Inc. in Princeton, NJ. Lot and expiration information is also included.*

FDA Label Image

Image3

This is the description of a Sevelamer Carbonate medication, which comes in an oral suspension form with lemon flavor. The medication is distributed by Bionpharma and contains 0.8g packets, with 90 packets per container. The text includes various codes and abbreviations related to the product, but there is no additional information beyond the medication's name and basic details.*

FDA Label Image

Image4

This is a prescription medication with the NDC number 69452-127-60 manufactured by BIONPHARMA. The medication is Sevelamer Carbonate and comes in the form of oral suspension with lemon flavor. No further information is available in the given text.*

FDA Label Image

Image5

This text provides instructions for using and storing a medication called sevelamer carbonate. Each packet contains 2.4 g of the medication, and the usual dosage should be determined by the package insert. To use, the packet should be opened, the medication emptied into water, stirred, and consumed within 30 minutes. The medication should be stored at 15°C to 30°C and protected from moisture. Distributed by Bionpharma Inc in Princeton, NJ.*

FDA Label Image

Image6

Sevelamer Carbonate is a medication used in oral suspension form for managing high levels of phosphorus in the blood of people with chronic kidney disease. This particular medication comes in a Lemon Flavor in a box that contains a total of 90 packets where each packet contains 2.4g of the medication. The medication is manufactured and distributed by BIONPHARMA with an NDC code of 6945212719. The recommended dosage is not mentioned, but it is advised to keep the medication out of reach of children and at room temperature between 68-77°F (20-25°C). The distribution and contact information for the manufacturer is also shown in the text.*

FDA Label Image

Figure 1: Structure Of Sevelamer Carbonate (Structure 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.